🇺🇸 Bisacodyl 5 MG in United States

14 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 2 reports (14.29%)
  2. Heart Rate Decreased — 2 reports (14.29%)
  3. Hyperhidrosis — 2 reports (14.29%)
  4. Vomiting — 2 reports (14.29%)
  5. Abasia — 1 report (7.14%)
  6. Abdominal Pain — 1 report (7.14%)
  7. Abdominal Pain Upper — 1 report (7.14%)
  8. Adverse Drug Reaction — 1 report (7.14%)
  9. Asthenia — 1 report (7.14%)
  10. Body Temperature Abnormal — 1 report (7.14%)

Source database →

Bisacodyl 5 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bisacodyl 5 MG approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bisacodyl 5 MG in United States?

Parc Taulí Hospital Universitari is the originator. The local marketing authorisation holder may differ — check the official source linked above.